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A B S T R A C T
Sphingosine kinase 1 (SK1) converts sphingosine to the bioactive lipid sphingosine 1-phosphate (S1P). S1P binds
to G-protein-coupled receptors (S1PR1–5) to regulate cellular events, including Ca2+ signaling. The SK1/S1P axis
and Ca2+ signaling both play important roles in health and disease. In this respect, Ca2+ microdomains at the
mitochondria-associated endoplasmic reticulum (ER) membranes (MAMs) are of importance in oncogenesis.
Mitofusin 2 (MFN2) modulates ER-mitochondria contacts, and dysregulation of MFN2 is associated with ma-
lignancies. We show that overexpression of SK1 augments agonist-induced Ca2+ release from the ER resulting in
increased mitochondrial matrix Ca2+. Also, overexpression of SK1 induces MFN2 fragmentation, likely through
increased calpain activity. Further, expressing putative calpain-cleaved MFN2 N- and C-terminal fragments in-
creases mitochondrial matrix Ca2+ during agonist stimulation, mimicking the SK1 overexpression in cells.
Moreover, SK1 overexpression enhances cellular respiration and cell migration. Thus, SK1 regulates MFN2
fragmentation resulting in increased mitochondrial Ca2+ and downstream cellular effects.
1. Introduction
Sphingosine kinase 1 (SK1) is a lipid kinase involved in multiple
pathologies, including cancer and severe neurological conditions [1,2].
SK1 acts by converting sphingosine into the signaling lipid sphingosine
1-phosphate (S1P), which is exported to the extracellular space for
auto/paracrine stimulation of the G-protein coupled S1P receptors 1–5
(S1PR1–5). S1P has been shown to have direct intracellular effects, in-
cluding modulation of intracellular calcium (Ca2+) signaling. Also,
there is evidence for the inter-regulation of SK1/S1P and Ca2+ sig-
naling, as SK1 activation is in part modulated by Ca2+ [3,4]. Being a
ubiquitous second messenger, Ca2+ regulates a wide variety of cellular
functions, such as proliferation, migration, respiration, neuronal func-
tion and cell death [5–8]. Aberrant intracellular Ca2+ signaling may
thus lead to pathological effects. The regulation of Ca2+ signaling is
tightly controlled and compartmentalized. The main intracellular Ca2+
store is the endoplasmic reticulum (ER). Also, mitochondria are
important players in intracellular Ca2+ handling, as they readily take
up Ca2+ and can act as Ca2+ buffers or sinks [9,10]. Importantly, Ca2+
is a key regulator of mitochondrial enzymes involved in ATP production
[7]. On the other hand, mitochondrial Ca2+ overload may lead to
programmed cell death [11]. Interactions between the ER and the mi-
tochondria are regulated at specific membrane contact sites between
the two organelles. The sites of the ER-membranes that are involved in
this inter-organellar regulation are thus named mitochondria-asso-
ciated membranes, or MAMs. For instance, lipid transfer and Ca2+ flux
are coordinated at the MAM sites [12,13]. Several proteins, including
mitofusin 2 (MFN2), have been found to reside at and to regulate the
dynamics of the MAM contacts [13,14]. Interestingly, opposing findings
concerning the effect of MFN2 expression/depletion on ER-mitochon-
dria tethering and mitochondrial Ca2+ signaling have been reported
[14–20].
The concept and importance of compartmentalized intracellular
Ca2+ signaling is actively studied with much emphasis put on the ER-
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mitochondria interactions and mitochondrial Ca2+ uptake [21,22].
Interestingly, S1P signaling is linked to mitochondrial biology. It has
been reported that S1P produced by the sphingosine kinase 2 (SK2)
isoform modulates mitochondrial respiration and antagonizes the
opening of the mitochondrial permeability transition pore (mPTP) in
ischemic heart tissue [23,24]. Also, S1P treatment (0.5–2mg/kg) after
experimental heart ischemia/reperfusion in rats suppresses the mPTP
opening and thus maintains the mitochondrial membrane potential,
which blunts the ischemic reperfusion injury [25]. Further, SK1 has
been recently shown to localize to mitochondria to activate the mi-
tochondrial unfolded protein response in C. elegans [26]. Also, inhibi-
tion of SK1 through reduced S1P levels induces mitochondrial dys-
function in pancreatic β-cells [27]. As mentioned earlier, S1P has been
shown to affect Ca2+ handling through unknown intracellular me-
chanisms as well as through the G-protein coupled S1P-receptors. Upon
activation, the S1PR1–4 couple to phospholipase C (PLC) to induce in-
ositol trisphosphate (IP3) generation which is followed by Ca2+ release
from the ER through the IP3-receptors [3]. Mitochondrial uptake of
Ca2+ that is released from the ER is coordinated at the MAM contact
sites [28]. Further, altered SK1/S1P signaling as well as disrupted Ca2+
signaling in the mitochondrial matrix and at the MAM sites, respec-
tively, have strong oncogenic implications [1,11,22,29]. Taken to-
gether, these observations led us to test whether SK1 overexpression
would affect Ca2+ handling at the ER-mitochondria compartments. For
this, we used a previously established HeLa cell model [30] over-
expressing human SK1 (hSK1), and genetically targeted aequorins for
the Ca2+ measurements [31]. We previously showed that the [Ca2+] in
caveolin-1 (Cav-1)-enriched microdomains was augmented by hSK1
overexpression as reported by the luminescent chimeric Cav-1-aequorin
[30]. However, SK1 overexpression did not significantly increase the
cytoplasmic [Ca2+] in HeLa cells during histamine-induced Ca2+ re-
lease [30]. Hence, in the present study, we characterized the effects of
SK1 overexpression on ER lumen ([Ca2+]ER) and mitochondrial matrix
Ca2+ concentrations ([Ca2+]mit).
2. Results
2.1. SK1 augments ER Ca2+ release and mitochondrial Ca2+ uptake
First, we examined mitochondrial matrix and luminal ER Ca2+
concentrations in mock-transduced and SK1-overexpressing (hSK1)
HeLa cells. The HeLa cell lines were as described in [30], and the SK1
overexpression is shown in Supplementary Fig. 1. The cells were chal-
lenged with the IP3-generating agonist histamine (100 μM) in the pre-
sence of the Ca2+ chelator EGTA (150 μM) in the extracellular buffer.
EGTA was added directly prior to the agonist stimulation to avoid un-
wanted emptying of the intracellular Ca2+ stores, and importantly, to
eliminate extracellular Ca2+ as a source for cytoplasmic Ca2+ entry
during agonist stimulation. In this experimental setting, both the re-
lease of ER Ca2+ as well as the Ca2+ uptake to the mitochondrial matrix
were significantly augmented in SK1-overexpressing cells (Fig. 1A, B).
[Ca2+]mit was significantly higher in hSK1 cells upon histamine sti-
mulation also when 1mM Ca2+ was present in the extracellular buffer
solution (Fig. 1C). These results indicate that the increased ER-derived
Ca2+ is effectively shunted to the mitochondria in SK1-overexpressing
cells. This is further highlighted by the previous results from our group
[30] that showed no SK1-induced changes in the cytoplasmic Ca2+. Of
note, SK1-overexpression did not lead to marked changes in the IP3-
receptor protein levels, indicating that the increased release of ER Ca2+
during histamine stimulation was not due to altered IP3R expression
(Suppl. Fig. 1). Importantly, also transient SK1-overexpression in both
HeLa and FTC-133 cell lines led to increased mitochondrial Ca2+ up-
take upon agonist stimulation (Suppl. Fig. 2A, B; and see Suppl. Fig. 5).
We then examined the possibility that SK1 overexpression would
affect the mitochondrial Ca2+ uptake per se. For this, the cells were
permeabilized by digitonin treatment in the presence of an intracellular
buffer (IB, supplemented with ATP) containing EGTA to chelate Ca2+
[31]. After plasma membrane permeabilization, the cells were perfused
with IB containing 4 μM free Ca2+ to allow for mitochondrial Ca2+
uptake [31]. In this setting, SK1 overexpression had no effect on
[Ca2+]mit as compared to the mock-transduced cells (Fig. 2A). This
finding is in line with the observation that SK1 overexpression did not
markedly alter the expression levels of the proteins involved in mi-
tochondrial matrix Ca2+ handling that were tested (MCU [32], MICU1
[33], MCUR1 [34], NCLX [35], AFG3L2 [36], OPA1 [37], Suppl.
Fig. 1). Next, we treated mock-transduced and SK1-overexpressing cells
with the ionophore ionomycin in the presence of EGTA. In this ex-
periment, the intracellular Ca2+ released by the ionomycin treatment
accumulated to a greater extent in the matrix of SK1-overexpressing cell
mitochondria (Fig. 2B). The effect of SK1 overexpression was more
pronounced when the cells were briefly incubated with the cytoplasmic
Ca2+ chelator BAPTA-AM prior to the ionomycin treatment (Fig. 2C).
Importantly, cytoplasmic calcium was unaffected in SK1-overexpressing
cells upon ionomycin treatment in the presence of EGTA (Fig. 2D).
These data thus suggest that SK1-overexpression augments the shunting
of intracellularly stored Ca2+ to the mitochondria, whereas the intrinsic
mitochondrial Ca2+ uptake capacity in permeabilized cells is not al-
tered by SK1.
2.2. SK1 overexpression induces cleavage of mitofusin-2
As we did not see any changes in the mitochondrial inner membrane
Ca2+ handling proteins, we asked whether SK1 affects the expression of
mitofusin-2 (MFN2), an essential regulator of mitochondrial fusion and
mitochondria-ER interactions at the MAM sites [38]. We found that the
levels of full-length MFN2 (~80 kDa) were not altered, but observed
that the SK1-overexpressing cells showed a distinct protein fragment
recognized by the N-terminal targeting anti-MFN2 antibody (Fig. 3A).
Intriguingly, calpain has been reported to induce MFN2 fragmentation
[39] and calpain is activated by S1P and an S1P analogue [40,41]. In
agreement with this, we observed an increase in calpain activity in SK1-
overexpressing cells (Fig. 3B). Of note, calpain activity was increased,
and a MFN2-fragment was identified, in HeLa and FTC-133 cells upon
transient SK1 overexpression. Further, long-term SK1-inhibitor treat-
ment reduced MFN2 fragment expression levels (Suppl. Fig. 3). MFN2
contains multiple putative calpain cleavage sites with the highest score
predicted for cleavage between the His467 and Arg468 residues (pre-
diction based on ref. [42] and conducted with the online tools at www.
calpain.org). Hence, we generated plasmid constructs to express MFN2
fragments that would result from calpain-mediated cleavage at the
putative His467-Arg468 site (Fig. 3C). Of note, the resulting fragments
include intact active domains of the full-length protein: the N-terminal
fragment harbors the GTPase, coiled-coil heptad repeat (HR1) and
proline rich (PR) domains, whereas the transmembrane (TM) and HR2
domains reside in the C-terminal fragment (see Fig. 3C and ref. [14] for
a schematic representation). Interestingly, the expression of both the N-
and C-terminal MFN2 fragments, respectively, was found to augment
the mitochondrial Ca2+ uptake (Fig. 3D), and similar results were ob-
tained when the FTC-133 cell line was used (Suppl. Fig. 2C). In contrast,
cytoplasmic Ca2+ was unaffected by MFN2 fragment expression
(Fig. 3E). These results indicate that the MFN2 fragments are biologi-
cally active and are able to modulate mitochondrial physiology in a
manner that is coupled to mitochondrial Ca2+ uptake. Importantly, this
is in agreement with the previous reports that have shown MFN2
fragment/mutant expression or MFN2-derived cell permeable short
peptides to be biologically active and to affect mitochondrial function
[43–45].
2.3. Mitochondrial Na+/Ca2+ exchanger activity is reduced by SK1
overexpression
The mitochondrial Na+/Ca2+ exchanger protein (NCLX) regulates
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the Ca2+ efflux from the mitochondrial matrix in a Na+-dependent
manner, and consequently, NCLX-inhibition leads to accumulation of
Ca2+ in the matrix [35,46]. Interestingly, the involvement of MFN2 in
the regulation of mitochondrial matrix Ca2+ by modulating the activity
of NCLX has been reported [47]. We conducted mitochondrial Ca2+
recordings during increasing agonist concentrations to study the ki-
netics of [Ca2+]mit upon repeated increases in intracellular [Ca2+]. In
this experiment, SK1-overexpressing cells again showed increased
[Ca2+]mit compared to the mock-transduced cells (Fig. 4A). To assess
the possible involvement of NCLX, the cells were treated with the NCLX
inhibitor CGP-37157 (CGP). Blocking NCLX did not significantly affect
the [Ca2+]mit in cells overexpressing SK1, whereas the mock-trans-
duced cells showed an increase in [Ca2+]mit when NCLX was inhibited
(Fig. 4B). This experiment suggests that the basal NCLX activity is low
in SK1-overexpressing cells, contributing, at least in part, to the accu-
mulation of Ca2+ in the mitochondrial matrix.
2.4. Overexpression of SK1 or the MFN2 N- and C-terminal fragments has
no effect on mitochondrial-ER networks
As mitochondria-ER dynamics regulates Ca2+ signaling, we set out
to investigate whether SK1 or MFN2 N- and C-terminal fragment
overexpression, respectively, would have an effect on these organelles.
First, SK1 overexpression showed no significant effects on the appear-
ance of the ER-mitochondria networks as visualized by immuno-
fluorescence and confocal microscopy (Fig. 5A). The expression of
MFN2 N- and C- terminal fragments did not have an effect on the mi-
tochondrial network, whereas full-length MFN2 expression resulted in
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Fig. 1. The effect of SK1 overexpression on ER Ca2+
release and mitochondrial Ca2+ uptake. A)
Histamine-induced Ca2+ release from the ER is
greater in SK1-overexpressing HeLa cells than in the
mock-transduced controls. Targeted aequorins as de-
scribed in Section 4.2 were employed for Ca2+ mea-
surements in these compartments. The baseline ER
Ca2+ of the cells was recorded in an HBSS buffer
containing 1mM Ca2+. Thereafter, the cells were
perfused with HBSS containing 100 μM histamine and
150 μM EGTA when indicated by the arrow to induce
a rapid IP3-mediated Ca2+ release from the ER. Re-
presentative traces and quantification with S.E.M of
the percental ER Ca2+ release are shown, N=8 for
mock, N=9 for hSK1, ***P < 0.001. B) Mitochon-
drial Ca2+ was measured upon 100 μM histamine
treatment in the presence of 150 μM EGTA in the
buffer. Representative traces and quantification of the
change (Δ, delta) in [Ca2+]mit from basal to maximal
stimulated concentration are shown, N=11,
**P < 0.01. C) Mitochondrial Ca2+ was measured
after 100 μM histamine treatment in the presence of
1mM Ca2+ in the buffer. Representative traces and
quantification of Δ[Ca2+]mit are shown, N=7,
*P < 0.01.
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the previously reported mitochondrial clustering [44,48] (Fig. 5B). Of
note, SK1-GFP did not colocalize with the mitochondria (Fig. 5C).
Further, we performed electron microscopy to analyze the mitochon-
dria-ER network. In agreement with the results obtained by confocal
microscopy, the mitochondrial surface area or the mitochondria-ER
contacts were not affected by SK1 overexpression as evidenced by the
electron microscopy approach (Fig. 6).
2.5. SK1 does not affect proliferation but increases cell respiration and
migration
Finally, we set out to characterize other possible physiological ef-
fects of SK1 overexpression. As Ca2+ is an important regulator of me-
tabolism and mitochondrial ATP production, we measured cellular re-
spiration. We found that SK1 overexpression slightly but significantly
increased the basal oxygen consumption in HeLa cells (Fig. 7A). Fur-
ther, mitochondrial Ca2+ is of importance in the regulation of cancer
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Fig. 2. Effect of SK1 overexpression on mitochondrial Ca2+ in
permeabilized cells during Ca2+ addition as well as in intact
cells during ionomycin treatment. Mitochondria-targeted ae-
quorin was employed in the experiment shown in panels A–C,
whereas the Ca2+ indicator Fura-2-AM was used for the mea-
surements shown in panel D, see Section 4.2. A) To permea-
bilize the plasma membrane, the cells were treated with 25 μM
digitonin in an intracellular buffer (IB, see the text and ref.
[31]) in the presence of EGTA. Then, the cells were perfused
with IB containing 4 μM free Ca2+ to allow for mitochondrial
Ca2+ uptake (as described in [31]. In this setting, no significant
differences between hSK1 and mock-transduced cells could be
detected, N= 9 for mock, N=8 for hSK1. B) The cells were
treated with 5 μM ionomycin in the presence of 150 μM EGTA
in the extracellular buffer when indicated by the arrow.
[Ca2+]mit was significantly higher in SK1-overexpressing cells,
N= 4 for mock, N=5 for hSK1. C) The cells were pretreated
with BAPTA-AM for 2.5min prior to treating the cells with
5 μM ionomycin in the presence of 150 μM EGTA. The brief
BAPTA-AM treatment resulted in significant reduction in io-
nomycin-induced [Ca2+]mit in the mock-transduced cells as
compared to the SK1-overexpressing cells, N= 5 for mock,
N=6 for hSK1. D) Cytoplasmic Ca2+ was not affected by SK1
overexpression during 5 μM ionomycin treatment in the pre-
sence of 150 μM EGTA in the extracellular buffer, N=4. The
bar diagrams show the average of the change (Δ) from basal to
maximal [Ca2+]mit recorded during each experiment. The error
bar shows S.E.M. *= P < 0.05, ***=P < 0.001, ns= not
significant.
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Fig. 3. Mitofusin-2 is fragmented in SK1-overexpressing cells, and transient MFN2 fragment expression increases mitochondrial Ca2+. Mitochondria-targeted, or non-
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cell proliferation [49]. However, SK1-overexpression did not affect
proliferation (Fig. 7B). Finally, we observed an SK1-induced increase in
cell migration (Fig. 7C). This finding is in line with the various me-
chanisms reported by which mitochondrial Ca2+ may regulate cell
migration [50], and with the widely reported effects of SK1/S1P/S1P-
receptor signaling on cancer cell migration and invasion [1,51,52].
3. Discussion
Aberrant sphingosine kinase 1/2 (SK1/2) expression and deregu-
lated S1P signaling have been previously associated with severe con-
ditions such as cancer, cardiovascular pathologies, inflammation, dia-
betes and neurological disorders [1,29]. Here, we show that SK1
overexpression modulates several important physiological parameters
in HeLa cervical cancer cells. First, we show that SK1 overexpression
significantly augments the IP3-induced release of ER Ca2+, and that the
released Ca2+ is taken up by the mitochondria. The mechanisms un-
derlying SK1-induced ER Ca2+ release and the following mitochondrial
Ca2+ uptake could be many. Firstly, SK1 activation is modulated by
Ca2+ [3]. Histamine-induced Ca2+ flux to the cytoplasm may thus
activate SK1 leading to S1P production, which would amplify the IP3
production in SK1-overexpressing cells through auto/paracrine stimu-
lation of the G-protein coupled S1P-receptors. However, short-term
blocking of the S1P receptors did not specifically abolish the effect of
SK1 overexpression on mitochondrial Ca2+ (Suppl. Fig. 4A). Hence, the
autocrine/paracrine S1P signaling loop does not play a major role here.
S1P has been reported to have direct intracellular effects, including the
release of Ca2+ from intracellular stores [3,53]. However, treatment
with SK1 inhibitor (SKi, 10 μM, 1 h) did not abolish the effects of stable
SK1 overexpression on mitochondrial Ca2+ (Suppl. Fig. 4B). Thus, in-
stead of acute S1P-mediated effects, these findings indicated that SK1
overexpression has a long-term effect on ER-mitochondrial Ca2+
handling.
The robust increase in the [Ca2+]mit induced by SK1 overexpression
initially suggested that some of the recently characterized components
of the mitochondrial calcium uniporter (MCU) might be affected
[10,42]. However, no changes in the expression levels of the tested
MCU components were found. In agreement with this, the intrinsic
mitochondrial Ca2+ uptake capacity was not affected by SK1 over-
expression. To further elucidate the nature of the SK1-mediated in-
crease in [Ca2+]mit, we first treated the cells with ionomycin in the
presence of the extracellular Ca2+ chelator EGTA (to induce rapid de-
pletion of stored intracellular Ca2+). In these conditions, SK1-over-
expressing cells show higher [Ca2+]mit than the mock-transduced cells.
We then included a short incubation with the intracellular Ca2+ buffer
BAPTA-AM in this experimental protocol [54]. The brief BAPTA-AM
treatment blunted the ionomycin-induced mitochondrial Ca2+ uptake
in mock-transduced cells, whereas the mitochondria in SK1-over-
expressing cells were able to effectively accumulate Ca2+. The results
from the ionomycin treatments thus indicate an altered interaction
between the mitochondria and the intracellular Ca2+ deposits (mainly
the ER) in SK1-overexpressing cells. In addition, the previous finding
that cytoplasmic Ca2+ was unaffected by SK1 overexpression upon io-
nomycin treatment (ref. [30]) corroborates the interpretation that SK1
somehow affects the Ca2+ flux between the ER and mitochondria.
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Fig. 4. SK1-overexpressing cell mitochondria accumulate Ca2+ more effec-
tively than the mock-transduced control cells during stimulation with in-
creasing histamine concentrations, and inhibition of the mitochondrial Na+/
Ca2+ exchanger NCLX augments mitochondrial Ca2+ retention in the mock-
transduced cells. Mitochondria-targeted aequorin was employed in the Ca2+
experiments shown. A) SK1-overexpressing HeLa cells were treated with in-
creasing histamine concentrations and mitochondrial matrix Ca2+ was mea-
sured. SK1 overexpression augmented [Ca2+]mit during all stimulations. Area
under curve (AUC) analysis was conducted on the selected timeframe of the
experiment (a′) and quantified in (a″), N= 4. B) Inhibition of the mitochondrial
Na+/Ca2+ exchanger NCLX by CGP-37157 (CGP; 10 μM, 1 h) increases the
accumulation of mitochondrial matrix Ca2+ in mock-transduced cells to a level
resembling that of SK1-overexpressing cells. The AUC was analysed between
the experimental time points shown in (b′) and the acquired values were ana-
lysed (b″), N= 4 vehicle-treated mock and hSK1, N=3 for CGP-treated mock
and hSK1. The average AUC from the shown time points is quantified in the bar
diagrams and the error bars depict S.E.M. *P < 0.05, **P < 0.01.
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Fig. 5. Analysis of mitochondrial and ER network, as
well as SK1 localization by employing confocal micro-
scopy analysis. A) SK1-overexpression does not alter the
mitochondria-ER network in HeLa cells. The panels show
composite (left), anti-PDIA3 stained (ER-marker, middle)
and mitotracker stained (right) representative confocal
microscopy images. B) Control transfection (pcDNA) or
MFN-2 C- or N-terminal (MFN2-cT; MFN2-nT) fragment
overexpression do not alter the mitochondrial network,
whereas full-length MFN-2 (MFN2-FL) overexpression
leads to the previously reported clustering of mitochon-
dria [44,48]. Co-expression of GFP with the pcDNA,
MFN2-cT and MFN2-nT was employed to indicate the
transfected cells. Mitochondrial network was visualized
by mitotracker. Overexpressed MFN2 was detected by
the anti-MFN2 antibody. C) SK1 does not localize to
mitochondria in HeLa cells as evidenced by SK1-GFP and
mitotracker.
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The results indicated that SK1 might modulate the ER-mitochondria
interactions. However, confocal or electron microscopy revealed no
changes in the ER-mitochondria organelle network or contacts, or mi-
tochondrial surface area, upon SK1 overexpression. Nevertheless, we
found that SK1 induces fragmentation of the MFN2 protein, which is a
positive regulator of mitochondrial fusion, and, in addition, regulates
the ER-mitochondria dynamics [14]. As mentioned before, whether
MFN2 promotes or hinders the ER-mitochondria tethering is debated
[14–20]. However, there is well-established evidence that MFN2 plays
an important role in mitochondrial physiology [14]. Our results show
that the expression of putative calpain-cleaved MFN2 N- and C- term-
inal fragments augments [Ca2+]mit upon agonist stimulation. Intrigu-
ingly, a truncated, non-fusogenic form of MFN2 has been previously
shown to have an effect on mitochondrial metabolism, and MFN2
fragments lacking the transmembrane domain re-establish mitochon-
drial targeting and activity when co-expressed with the C-terminal and
the transmembrane domain MFN2 fragments [43,44]. Thus, MFN2
fragments are able to interact and retain (some degree) of their func-
tionality. Also, short peptide fragments of MFN2 coiled-coil heptad
repeat region (HR)-domains have been shown to bind to and modulate
MFN2 functions [45]. Thus, protein fragments and/or peptide deriva-
tives of MFN2 have been shown by others, and by us in the present
study, to be biologically active. Further, glutamate-induced calpain
activation has been shown to induce MFN2 degradation [39]. These
findings are in line with our results showing an SK1-induced calpain
activation and MFN2 fragmentation. Interestingly, calpain may localize
to caveolae and we have previously shown that SK1-overexpression
augments Ca2+ signaling at the caveolar sub-compartment without
affecting the overall cytoplasmic Ca2+ [30,55]. As mentioned above, it
is debated whether MFN2 antagonizes or augments mitochondrial Ca2+
[14–16]. Our results suggest that MFN2 fragment expression increases
mitochondrial Ca2+, but whether this effect is through inhibitory or
Fig. 6. Assessment of mitochondrial surface area and ER-mitochondrial contacts by electron microscopy. Areas of mitochondria-ER contact (brackets, at higher
magnification at right) are equivalent in mock and hSK1 cells. The bar diagrams show the total surface area of mitochondria (μm2/μm3 of cytoplasm) and mi-
tochondrial surface area in contact with the ER (μm2/μm3 of cytoplasm), respectively. Scale bar= 1 μm (left) and 500 nm (right). N= two independent experiment
with 60 mock cell profiles and 60 hSK1 cell profiles analysed, respectively.
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activating interactions with endogenous MFN2, or through other ef-
fects, remains to be clarified.
Charcot-Marie-Tooth (CMT) disease is a neuropathy with multiple
known contributing factors leading to the disease phenotype [56].
MFN2 mutations are associated with CMT type 2A (CMT2A) [57]. In-
terestingly, as evidenced by a Drosophila model, mutant MFN2 expres-
sion causes a CMT2A-resembling phenotype through excessive mi-
tochondrial fusion or fission, respectively, depending on the site of
mutation [58]. Further, S1P lyase deficiency is found in CMT patients,
leading to increased S1P plasma levels [59]. SK1 overexpression might
resemble S1P lyase deficiency as S1P levels are expected to increase in
both conditions [1]. Also, disturbed Ca2+ homeostasis and mitochon-
drial dysfunction has been observed in a CMT model [60]. Given the
recent pre-clinical advances in targeting mutant MFN2 in CMT2A
models [57], and the fact that S1P signaling can be pharmacologically
targeted [61], it would be interesting to test whether MFN2 is affected
in patients with S1P lyase dysfunction.
MFN2 has been shown to modulate mitochondrial Ca2+ through
affecting the activity of the mitochondrial matrix Ca2+/Na+ exchanger
NCLX in conditions where mitochondrial membrane potential is re-
duced [47]. Intriguingly, we found that mitochondrial membrane po-
tential was reduced in SK1-overexpressing cells (Suppl. Fig. 3D). We
observed that inhibition of NCLX did not significantly affect the mi-
tochondrial Ca2+ dynamics in SK1-overexpressing cells, whereas the
mock-transduced control cells showed increased accumulation of mi-
tochondrial Ca2+ when extrusion of Ca2+ through NCLX was blocked.
Also, it has been very recently reported that reduced mitochondrial
membrane potential inhibits NCLX activity leading to accumulation of
[Ca2+]mit ([62]; NCLX regulation reviewed in [63]). It is therefore
possible that altered NCLX activity in SK1-overexpressing cells might,
in part, account for the observed increase in [Ca2+]mit.
The SK1-induced alterations in ER-mitochondrial Ca2+ handling
may be of relevance in regard to the oncogenic functions of SK1, since
the importance of Ca2+ signaling at the MAM sites in cancer is well-
acknowledged [11,64]. The SK1-induced increase in mitochondrial
matrix Ca2+ may affect cell energetics as [Ca2+]mit regulates ATP
production [10,65]. Further, mitochondrial Ca2+ has been shown to
modulate cell migration [50]. Interestingly, we observed an SK1-
mediated increase in cell respiration and migration, which is in
agreement with the effects of altered [Ca2+]mit. The involvement of
MFN2 in the regulation of mitochondrial Ca2+ is mechanistically
complex and partially unclear as evidenced by multiple previous studies
([47], reviewed in [14]). Our data suggests that SK1, through frag-
mentation of MFN2 and possibly through the modulation of NCLX ac-
tivity causes alterations in the mitochondrial Ca2+ handling. Further
studies are needed to clarify the mechanistic details of MFN2 and mi-
tochondrial Ca2+ dynamics. Taken together, our results show aug-
mented mitochondrial Ca2+ uptake upon SK1 overexpression, with
implications for the regulation of cell respiration and migration, pro-
viding novel insights to the oncogenic role of SK1 (schematic re-
presentation; Fig. 8).
4. Materials and methods
4.1. Cell culture, plasmids and transfections
HeLa [30] and human follicular thyroid cancer FTC-133 [66] cell
lines were used in this study. The HeLa cells were grown in a humidi-
fied and thermostatic incubator with a controlled atmosphere (37 °C,
5% CO2) in DMEM medium (#D6046, Sigma-Aldrich) supplemented
with 10% fetal bovine serum and 1% penicillin/streptomycin (Life
Sciences). The FTC-133 cells were cultured in DMEM and F12 (Ham's
nutrient) medium (1:1) supplemented with 10% FBS, 1% P/S and 2mM
L-glutamine. Plasmid transfections were carried out by employing
TurboFect (#R0531, Thermo Scientific) transfection reagent and Op-
tiMEM media (#31985-070, Life Technologies), or by electroporation
(4,000,000 cells with 20 μg of the desired plasmid suspended in 400 μL
OptiMEM; 240 V; 500 μF). The stable SK1-overexpressing and mock-
transduced HeLa cell lines, respectively, were created as described
previously [30]. SK1-EGFP plasmid (SK1-GFP) was as described pre-
viously [67,68] the GFP plasmid (EGFP) was as in [69], and the GFP
plasmid used in Fig. 5 was from Clontech (EGFP, #6085-1). Full length
human MFN2, NT and CT fragments were cloned from human Nthy-ori
3.1 cell cDNA and inserted into pcDNA3 with HindIII and BamHI. All
constructs were verified by Sanger sequencing. Primer sequences used
are available upon request. Aequorin plasmids were as described in
[31].
4.2. Ca2+ measurements
For compartment-specific Ca2+ measurements, we used lumines-
cent aequorin chimeras [31] genetically targeted to the sarco/en-
doplasmic reticulum (mutated aequorin), to the mitochondrial matrix
(wild-type aequorin) and to the cytoplasm (wild-type, no targeting se-
quence). These measurements were conducted as described previously
by employing an in-house built luminometry setup or by utilizing a
plate reader [31,69]. Briefly, the cells were plated either on to 12-well
plates (100,000 cells per well) containing poly-L-lysine coated 13mm
coverslips, or, when employing a HIDEX Sense plate reader (HIDEX
corp., Turku, Finland), on to 96-well plates (10,000 cells per well). The
cells were transfected with the desired plasmid constructs (1 μg
plasmid/ml medium, final total plasmid concentration on each well).
Twenty-four hours post-transfection the cells were incubated in HBSS
buffer (118mM NaCl, 4.6mM KCl, 10mM glucose, 20mM HEPES,
pH 7.4) supplemented with 5 μM coelenterazine and 1mM CaCl2 (mi-
tochondrial and cytoplasmic measurements) or 5 μM coelenterazine n
along with 100 μM EGTA and 1mM ionomycin (endo/sarcoplasmic
measurements). Mitochondrial aequorin measurements in permeabi-
lized cells were conducted exactly as described by Bonora et al. [31].
The cytoplasmic fluorescent Ca2+ indicator Fura-2-AM (Life Technol-
ogies) was employed as described in [69].
4.3. Western blot and antibodies
Western blotting was conducted as described previously [30].
Briefly, cells well were seeded onto 100mm or 35mm cell culture
plates. At approximately 70% confluence, the cells were washed with
phosphate buffered saline solution (PBS) and then harvested in a lysis
buffer (10mM Tris, 150mM NaCl, 7 mM EDTA, 0.5% NP-40, 0.2 mM
PMSF, and 0.5 μg/ml leupeptin, pH 7.7). The mitochondrial isolation
was conducted as described in [70]. The lysates were supplemented
with Laemmli sample buffer (LSB) and boiled for 5min. The proteins
were separated by SDS-PAGE and transferred to a nitrocellulose mem-
brane by wet transfer. The membranes were incubated overnight with
the primary antibodies and then with the horseradish peroxidase (HRP)
–conjugated secondary antibodies. The protein bands were detected by
chemiluminescence (WesternLightning, PerkinElmer, USA). The anti-
bodies were: Anti-SK1 (Cell Signaling, #32975 [Suppl. Fig. 1] and
#12071 [Suppl. Fig. 5]), Anti-Mitofusin-2 (M6319, Sigma-Aldrich),
Anti-MCU antibody (HPA016480, MERCK), Pan-IP3R antibody IP3R1/
2/3 H300 (sc-28613, Santa Cruz Biotechnology), Anti-CBARA1/MICU1
antibody (ab102830, Abcam), anti-GFP antibody (ab290, Abcam),
AFG3L2 Polyclonal (#14631-1-AP, Proteintech), anti-OPA1, anti-
MCUR1, Anti-mouse IgG HRP-linked secondary, Anti-Rat IgG HRP-
linked secondary antibodies were from Cell Signaling Technology. Goat
Anti-Rabbit IgG (H+ L)-HRP Conjugate (#1706515, Biorad). Anti-
HSC70 (ADI-SPA-815, Enzo Life Sciences) and anti-VDAC1 (MABN504,
Merck) antibodies served as loading controls for whole cell and mi-
tochondrial lysates, respectively. The anti-NCLX antibody [35] was a
kind gift from professor Israel Sekler. The anti-IP3R1 (rbt03) antibody
was described in [71]. In addition, antibodies that were used only for
immunocytochemistry were: Anti-protein disulfide-isomerase A3
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(PDIA3, AMAB90988, Sigma), Alexa Fluor 488 conjugate (A-11017
Mouse, A-11008 Rabbit, Life Technologies).
4.4. Cell migration and proliferation
Corning Transwell membrane inserts were employed to study cell
migration according to a protocol modified from [72]. Briefly, 75,000
cells were collected in serum-free medium and allowed to migrate
through uncoated Transwell membrane inserts for 12 h. Fetal bovine
serum (FBS) was utilized as a chemoattractant. Then, the membranes
were processed as described in [72] and the migrated cells were
manually counted. The normalized cell counts were statistically ana-
lysed. Cell proliferation was measured by a thymidine incorporation
assay at 48 h after seeding the cells as previously described in ref. [69].
4.5. Electron microscopy
For electron microscopy cells were fixed with 2.5% glutaraladehyde
in 0.1 M cacodylate buffer, scraped and pelleted in gelatin, postfixed
with 1% osmium tetroxide and 1.5% potassium ferrocyanide, dehy-
drated and embedded in an Epon resin. Ultrathin sections were post-
stained with uranyl acetate and lead citrate and 30 cell profiles from
each culture were systematically sampled and photographed at 6000×
with a Jeol JEM-1400 electron microscope equipped with a Gatan Orius
SC 1000B bottom mounted CCD-camera. The pictures were viewed at a
final magnification of 160,000×. A regular line grid was overlaid and
the surface to volume ratios of mitochondrial outer surface membrane
and mitochondrial membrane in close contact with the ER were de-
termined according to the formula S/V= 4c/lh, where c is the number
of times the lines intersected the surface of interest, h is the number of
times the end points of the lines fell on cytoplasm and l is the length of a
test line [73]. The graphs represent the results from 2 experiments
(n=2, in all 60 mock cell profiles, 60 hSK1 cell profiles).
4.6. Calpain activity assay
A calpain activity assay kit (#ab65308, Abcam, Cambridge, MA,
USA) was employed. The assay was performed according to the man-
ufacturer's instructions as described previously [66]. Briefly, 2,000,000
cells were grown overnight on 100-mm cell culture plates. The next
day, the cells were detached and washed three times with PBS. Fluor-
escence was measured using a Hidex sense microplate reader instru-
ment (HIDEX Corp, Turku, Finland) with the excitation light set at
400 nm and emitted light collected at 505 nm.
4.7. Cellular oxygen consumption measurements
For the oxygen consumption measurements, 10,000 HeLa cells per
well were seeded onto a 96-well Agilent Seahorse XF Cell Mito Stress
Test Kit plate and the measurements were conducted as defined in the
manufacturer's protocol. To study the different mitochondrial respira-
tion pathways, the cells were sequentially challenged with 1 μM oli-
gomycin, 1 μM Trifluoromethoxy carbonylcyanide phenylhydrazone
(FCCP) and 0.5 μM rotenone + 0.5 μM antimycin A, respectively.
4.8. Immunocytochemistry
The cells were seeded on 35mm coverslips in 6-well plates the day
before transfection. Cells were cultured and transfected as described in
Section 4.1. Sixteen hours after transfection, the cells were incubated
with MitoTracker-Red (MitoTracker® Red FM, M22425, Thermo) for
20min, then fixed with 4% paraformaldehyde for 10min at room
temperature and rinsed in PBS three times. Permeabilization and block
was performed in PBS containing 5% FBS and 0.3% (v/v) Triton X-100
for 5min at room temperature. The cells were then incubated with
appropriate primary antibodies (as listed below) for 90min at 37 °C in
the dark. After rinsing, the cells were incubated with corresponding
secondary antibody for 1 h at 37 °C in the dark. All antibodies were
diluted in blocking solution (5% FBS). The cells were then washed three
times with PBS for 15min and mounted with Vectashield Mounting
Media with DAPI (H-1200, Vector Laboratories). Cells were imaged
with 3i (Intelligent Imaging Innovations) CSU-W1 Confocal Spinning
Disk Microscope (Yokogawa Corporation of America) equipped with
Hamamatsu sCMOS Orca Flash 4 (Hamamatsu Photonics), using 63×
oil immersion. Also used was Zeiss LSM 780 Confocal Microscope
(Zeiss, Germany) with a 63× water immersion objective. The excita-
tion/emission wavelengths (nm) used were: green (GFP), 498/516; and
red (DsRed), 558/583. Image acquisition was performed with Slide-
Book v 6.0 and Zeiss Zen, respectively. Image processing was done
using Fiji (ImageJ plugin collection) [74].
4.9. Mitochondrial membrane potential measurements
The cells were plated on to 24-well plates and treated on the next
day with tetramethylrhodamine ethyl ester perchlorate (TMRE) for
20min in the cell culture conditions as described in 4.1. The control
Fig. 8. Schematic representation of the proposed model. Sphingosine kinase 1 (SK1) phosphorylates sphingosine to form sphingosine 1-phosphate (S1P), which
promotes calpain activation and consequent cleavage of mitofusin-2 (MFN2) at histidine 467. The cleaved fragments of MFN2 contain the functional GTPase and
heptad-repeat 1 (HR1) domains, as well as the transmembrane (TM) and heptad-repeat 2 (HR2) domains, respectively. The MFN2 fragmentation modulates mi-
tochondria-endoplasmic reticulum (ER) dynamics and inhibits the mitochondrial sodium‑calcium (Ca2+) exchanger NCLX, leading to increased mitochondrial matrix
Ca2+ concentration ([Ca2+]). Then, mitochondrial Ca2+ augments respiration and cell migration.
I. Pulli, et al. BBA - Molecular Cell Research 1866 (2019) 1475–1486
1484
cells were treated with 100 μM FCCP 10min prior to TMRE treatment.
Thereafter, the cells were briefly washed in PBS containing 0.2% bovine
serum albumin, and the TMRE fluorescence was read by utilizing a
plate reader (HIDEX Sense, Hidex, Finland). Values obtained from a
colorimetric crystal violet assay [75] was used to normalize the ac-
quired TMRE fluorescence values.
4.10. Statistics
Statistical analysis was conducted by unpaired Student's t-test when
two means were compared or by One-Way Anova with Tukey's post-hoc
test when three or more means were compared. The GraphPad Prism 6
program (GraphPad Software Inc., San Diego, CA) was employed for the
statistical analyses. A P-value below 0.05 was considered statistically
significant.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.bbamcr.2019.06.006.
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